分流储备或OCT以指导复杂和非复杂的血管学中介冠状动脉狭窄症的管理
Andrea Zito1, Francesco Burzotta2, Cristina Aurigemma3
1Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.
Revista espanola de cardiologia (English ed.)
|March 19, 2025
概括
光学连贯断层扫描 (OCT) 可能有利于复杂的冠状动脉病变,而分流储备 (FFR) 可能有利于非复杂的病变. 血管学损伤的复杂性影响了OCT与FFR在冠状动脉疾病管理中的长期疗效.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗成像医学成像
背景情况:
- 冠状动脉疾病 (CAD) 的管理从改进的功能或解剖评估中受益.
- 血管学中介性冠状动脉病变需要精确的管理策略.
研究的目的:
- 为了比较光学连贯断层扫描 (OCT) 和分流储备 (FFR) 指导的有效性.
- 在中间冠状动脉病变中,根据血管学损伤复杂性评估指导模式的有效性.
主要方法:
- FORZA试验是一项随机试验,比较了OCT和FFR指导.
- 患有中级冠状动脉病变的患者接受了重新血管化的决定和PCI优化.
- 复杂的病变被定义为长度,化或分叉参与. 主要结局是主要的心脏不良事件 (MACE).
主要成果:
- 在5年的随访中,MACE发生率在复杂病变中为20.8%,在非复杂病变中为13.9%.
- 与FFR相比,OCT指南显示复杂病变中的MACE风险较低 (P=.044).
- 与OCT相比,FFR指南显示非复杂病变的MACE风险较低 (P=.040),具有显著的相互作用 (P=.004).
结论:
- 血管学损伤的复杂性调节了OCT与FFR在中间冠状动脉损伤中的长期疗效.
- 在复杂的冠状动脉病变中,OCT指南可能会带来好处.
- 在非复杂的冠状动脉病变中,FFR指导可能更有效.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...


